Merck KGaA opened a collaborative bio/pharma development facility in Molsheim, France and announced an investment plan through 2025 for its Darmstadt, Germany headquarters. / read more /
The organizers of Pharmapack Europe have revealed their prediction that the drug delivery and healthcare packaging industry will experience significant growth during 2019. / read more /
The companies announced a collaboration to jointly discover and develop treatments to address unmet medical needs in a specific neurological disease. / read more /
EMA has issued advice to healthcare professionals and patients on the potential increased risk of blood clots in the lungs and death with higher than recommended doses of Xeljanz (tofacitinib) in the treatment of rheumatoid arthritis. / read more /
The guidance provides nonclinical and clinical recommendations to sponsors for the development of products for the prevention of HIV-1 infection. / read more /
The companies aim to assess automated CAR-T cell therapy manufacturing at the point-of-care and develop technologies to facilitate patient access to immunotherapies. / read more /
The company received $4.8 million from the Bill & Melinda Gates Foundation to accelerate global health research in the development of vaccines and antibody-based treatments for infectious diseases. / read more /
While allogeneic therapies can use existing regulatory and quality frameworks, autologous treatments will require pharma's adoption of true just-in-time and right-first-time concepts, says consultant James Blackwell. / read more /
Optical coherence tomography can improve quality control and development of coated dosage forms by allowing film thickness to be measured in real time. / read more /
MALDI-8020: Small size. Massive impact
The MALDI-8020 is the latest in a long line of MALDI-TOF products from Shimadzu. This benchtop, linear MALDI-TOF mass spectrometer delivers outstanding performance in a compact footprint, making it an ideal choice for today's increasingly demanding laboratories. / Read more/
The editors explore new tools for bio/pharma lab studies—such as robotics, augmented reality, and advanced instrumentation—as well as best practices for method development, multiple attribute monitoring, lab mixers, and raw material testing.
